Intermountain Healthcare has received a grant from the National Institutes of Health to study the implementation of computerized clinical support for mechanical ventilation in patients with Acute Respiratory Distress Syndrome (ARDS). The study will be led by Colin K. Grissom, MD, and Raj Srivastava, MD, assistant vice president of Research.  ARDs is a progressive condition that can occur in patients who are critically ill or have significant trauma. The main complication of ARDS is that fluid leaks into the lungs, making breathing difficult or impossible due to a lack of oxygen in the blood. ARDS is associated with very high morbidity, mortality, and healthcare cost.  The awarding of the NIH grant highlights the purpose of research at Intermountain—to invest in research that will have a rapid impact on care delivery. Research at Intermountain is focused on achieving the best medical result at the lowest necessary cost. “When physicians and caregivers use evidence-based practices, they are making care safer and better for patients,” says Mark Briesacher, MD, senior vice president, chief physician executive and president of Intermountain Medical Group. “Receiving this grant underscores the importance of Intermountain’s clinicians, researchers, and caregivers teaming up to help people recover from serious illnesses and get back to health.”

Source: EIN News

Pin It on Pinterest